TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Tenaya Therapeutics Stock

Tenaya Therapeutics Stock

tenayatherapeutics.comHealthcareFounded: 2016Funding to Date: $142MM

Tenaya Therapeutics is a biopharmaceutical company focused on addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.

Learn more about Tenaya Therapeutics IPO
Register for Details

For more details on financing and valuation for Tenaya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tenaya Therapeutics.

Register Today

Team

Management Team

JJ Kang Ph.D
President & Board Member
Benoit Bruneau Ph.D
Scientific Co-Founder
Sheng Ding Ph.D
Co-Founder
Timothy Hoey Ph.D
Chief Scientific Officer
Bruce Conklin MD
Scientific Co-Founder
Whittemore Tingley Ph.D
Chief Medical Officer
Faraz Ali
Board Member & Chief Executive Officer
Deepak Srivastava MD
Scientific Co-Founder & Board Member
Saptarsi Haldar MD
Scientific Co-Founder
Eric Olson Ph.D
Scientific Co-Founder

Board Members

David Goeddel Ph.D
The Column Group
Jin-Long Chen Ph.D
Deepak Srivastava MD
Faraz Ali
JJ Kang Ph.D
Anthony Philippakis MD
GV
Eli Casdin
Casdin Capital
Robert Sanders Williams MD

Other companies like Tenaya Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Pulse 2.0 10/11/2019
Tenaya Therapeutics Raises $92 Million In Funding To Deliver Curative Heart Disease Therapies
Tenaya Therapeutics, a company aiming to discover and develop curative therapies that target the underlying causes of heart disease, has raised $92 million.
PR Newswire 10/03/2019
Tenaya Therapeutics Closes $92 Million Series B Financing
/PRNewswire/ -- Tenaya Therapeutics, Inc., a company with a mission to discover, develop, and deliver curative therapies that target the underlying causes of...

Trending Companies

Frequently Asked Questions